Israel - English - Ministry of Health

megapharm ltd - trabectedin - powder for concentrate for solution for injection - trabectedin 1 mg/vial - trabectedin - trabectedin - yondelis is indicated for the treatment of patients with advanced soft tissue sarcoma, after failure of anthracyclines and ifosfamide, or who are unsuited to receive these agents. efficacy data are based mainly on liposarcoma and leiomyosarcoma patients.

Israel - English - Ministry of Health

megapharm ltd - hydrocortisone acetate; pramocaine hydrochloride - foam - pramocaine hydrochloride 0.9363 %w/w; hydrocortisone acetate 0.9363 %w/w - relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.

Israel - English - Ministry of Health

megapharm ltd - anethole; borneol; camphene; cineole; fenchone; pinene alfa; pinene beta - capsules - camphene 15 mg; cineole 3 mg; fenchone 4 mg; borneol 10 mg; anethole 4 mg; pinene beta 6.2 mg; pinene alfa 24.8 mg - as an adjuvant in infections of kidenys and urinary tract.

Israel - English - Ministry of Health

megapharm ltd - carbamazepine - tablets prolonged release - carbamazepine 300 mg - carbamazepine - carbamazepine - epilepsy, trigeminal neuralgia, diabetes insipidus mania, prophylactic in manic depressive illness.

Israel - English - Ministry of Health

megapharm ltd - carbamazepine - tablets prolonged release - carbamazepine 600 mg - carboxamide derivatives - treatment of epilepsy, trigeminal neuralgia, mania, prophylactic in manic depressive illness .

Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - irinotecan hydrochloride trihydrate, quantity: 20 mg/ml - injection - excipient ingredients: water for injections; sodium hydroxide; sorbitol; lactic acid - as a component of first line therapy for patients with metastatic carcinoma of the colon or rectum. patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - irinotecan hydrochloride trihydrate, quantity: 20 mg/ml - injection - excipient ingredients: water for injections; sorbitol; lactic acid; sodium hydroxide - as a component of first line therapy for patients with metastatic carcinoma of the colon or rectum. patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - nystatin, quantity: 100000 iu/ml - oral liquid - excipient ingredients: sodium hydroxide; carmellose sodium; saccharin sodium; sucrose; methyl hydroxybenzoate; sodium citrate dihydrate; purified water; propyl hydroxybenzoate; flavour - for the treatment of oral candidal infections only

Israel - English - Ministry of Health

megapharm ltd - lactulose - solution (oral) - lactulose 670 mg/ml - lactulose - lactulose - constipation. acute and chronic hepatic encephalopathy.

Israel - English - Ministry of Health

megapharm ltd - rifaximine - film coated tablets - rifaximine 200 mg - rifaximin - rifaximin - • casual treatment of diseases of grown-ups and youngsters from 12 years up, caused by bacteria in the gastrointestinal tract, sensitive to rifaximin:• hepatic encephalopathy • traveller’s diarrhea, caused by not-invasive enteropathogeneous bacteria.• non-complicated diverticular diseases.